Neutrophils and inflammatory resolution in the mucosa

Cohen, 1998 Ortega-Gomez, 2013, Resolution of inflammation: an integrated view, EMBO Mol. Med., 5, 661, 10.1002/emmm.201202382 Serhan, 2014, Pro-resolving lipid mediators are leads for resolution physiology, Nature, 510, 92, 10.1038/nature13479 Sousa, 2013, Pharmacological strategies to resolve acute inflammation, Curr. Opin. Pharmacol., 13, 625, 10.1016/j.coph.2013.03.007 Serhan, 2008, Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators, Nat. Rev. Immunol., 8, 349, 10.1038/nri2294 Spite, 2011, Novel lipid mediators promote resolution of acute inflammation: impact of aspirin and statins, Circ. Res., 107, 1170, 10.1161/CIRCRESAHA.110.223883 Serhan, 2007, Resolution of inflammation: state of the art, definitions and terms, FASEB J., 21, 325, 10.1096/fj.06-7227rev Ivanov, 2010, Cytoskeletal regulation of epithelial barrier function during inflammation, Am. J. Pathol., 177, 512, 10.2353/ajpath.2010.100168 Turner, 2009, Intestinal mucosal barrier function in health and disease, Nat. Rev. Immunol., 9, 799, 10.1038/nri2653 Koch, 2012, The life and death of epithelia during inflammation: lessons learned from the gut, Annu. Rev. Pathol., 7, 35, 10.1146/annurev-pathol-011811-120905 Kuhl, 2007, Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils, Gastroenterology, 133, 1882, 10.1053/j.gastro.2007.08.073 Zemans, 2009, Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury, Am. J. Respir. Cell Mol. Biol., 40, 519, 10.1165/rcmb.2008-0348TR Persson, 2010, Resolution of cell-mediated airways diseases, Respir. Res., 11, 75, 10.1186/1465-9921-11-75 Taylor, 2007, Hypoxia and gastrointestinal disease, J. Mol. Med., 85, 1295, 10.1007/s00109-007-0277-z Albenberg, 2014, Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota, Gastroenterology, 18, 1055, 10.1053/j.gastro.2014.07.020 Sheridan, 1990, Intraoperative tissue oximetry in the human gastrointestinal tract, Am. J. Surg., 159, 314, 10.1016/S0002-9610(05)81226-7 Miller, 2010, A short-breath-hold technique for lung pO2 mapping with 3He MRI, Magn. Reson. Med., 63, 127, 10.1002/mrm.22181 Furuta, 2001, Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia, J. Exp. Med., 193, 1027, 10.1084/jem.193.9.1027 Karhausen, 2004, Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis, J. Clin. Investig., 114, 1098, 10.1172/JCI200421086 Semenza, 2011, Oxygen sensing, homeostasis, and disease, NEJM, 365, 537, 10.1056/NEJMra1011165 Kelly, 2015, Host–microbe crosstalk between short-chain fatty acids and intestinal epithelial HIF provides a new mechanism to augment tissue barrier function, Cell Host Microbe, 10.1016/j.chom.2015.03.005 Kelly, 2013, Fundamental role for HIF-1alpha in constitutive expression of human beta defensin-1, Mucosal Immunol., 6, 1110, 10.1038/mi.2013.6 Campbell, 2014, Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation, Immunity, 40, 66, 10.1016/j.immuni.2013.11.020 Huang, 2004, Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease, Clin. Gastroenterol. Hepatol., 2, 690, 10.1016/S1542-3565(04)00292-7 Werlin, 1982, Colitis in chronic granulomatous disease, Gastroenterology, 82, 328, 10.1016/0016-5085(82)90023-3 Colgan, 2010, Hypoxia: an alarm signal during intestinal inflammation, Nat. Rev. Gastroenterol. Hepatol., 7, 281, 10.1038/nrgastro.2010.39 Karhausen, 2005, Inflammatory hypoxia: role of hypoxia-inducible factor, Cell Cycle, 4, 256, 10.4161/cc.4.2.1407 Comerford, 2002, Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene, Cancer Res., 62, 3387 Comerford, 2002, Role of vasodilator-stimulated phosphoprotein in PKA-induced changes in endothelial junctional permeability, FASEB J., 16, 583, 10.1096/fj.01-0739fje Eltzschig, 2003, Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors, J. Exp. Med., 198, 783, 10.1084/jem.20030891 Synnestvedt, 2002, Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia, J. Clin. Investig., 110, 993, 10.1172/JCI0215337 Cummins, 2008, The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis, Gastroenterology, 134, 156, 10.1053/j.gastro.2007.10.012 Han, 2003, Synergistic expression of inducible nitric oxide synthase by phorbol ester and interferon-gamma is mediated through NF-kappaB and ERK in microglial cells, J. Neurosci. Res., 73, 659, 10.1002/jnr.10706 Morote-Garcia, 2009, Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia, Gastroenterology, 136, 607, 10.1053/j.gastro.2008.10.037 Robinson, 2008, Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition, Gastroenterology, 134, 145, 10.1053/j.gastro.2007.09.033 Shah, 2008, Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade, Gastroenterology, 134, 2036, 10.1053/j.gastro.2008.03.009 Giatromanolaki, 2003, Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease, J. Clin. Pathol., 56, 209, 10.1136/jcp.56.3.209 Mariani, 2009, Cyclooxygenase-2 and hypoxia-inducible factor-1alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis, Cancer Lett., 279, 221, 10.1016/j.canlet.2009.02.001 Matthijsen, 2009, Enterocyte shedding and epithelial lining repair following ischemia of the human small intestine attenuate inflammation, PLoS ONE, 4, e7045, 10.1371/journal.pone.0007045 Louis, 2006, Selective induction of mucin-3 by hypoxia in intestinal epithelia, J. Cell. Biochem., 99, 1616, 10.1002/jcb.20947 Gilroy, 1999, Inducible cycloxygenase may have anti-inflammatory properties, Nat. Med., 5, 698, 10.1038/9550 Serhan, 2000, Anti-microinflammatory lipid signals generated from dietary N-3 fatty acids via cyclooxygenase-2 and transcellular processing: a novel mechanism for NSAID and N-3 PUFA therapeutic actions, J. Physiol. Pharmacol., 51, 643 Campbell, 2011, Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators, J. Immunol., 187, 3475, 10.4049/jimmunol.1100150 Eltzschig, 2014, Targeting hypoxia signalling for the treatment of ischaemic and inflammatory diseases, Nat. Rev. Drug Discov., 13, 852, 10.1038/nrd4422 Epstein, 2001, C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation, Cell, 107, 43, 10.1016/S0092-8674(01)00507-4 Jaakkola, 2001, Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation, Science, 292, 468, 10.1126/science.1059796 Fraisl, 2009, Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease, Nat. Rev. Drug Discov., 8, 139, 10.1038/nrd2761 Keely, 2014, Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis, Mucosal Immunol., 7, 114, 10.1038/mi.2013.29 Okumura, 2012, A new pharmacological agent (AKB-4924) stabilizes hypoxia inducible factor-1 (HIF-1) and increases skin innate defenses against bacterial infection, J. Mol. Med., 28, 1079, 10.1007/s00109-012-0882-3 Colgan, 2012, Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery, Annu. Rev. Physiol., 74, 153, 10.1146/annurev-physiol-020911-153230 Hasko, 2008, Adenosine receptors: therapeutic aspects for inflammatory and immune diseases, Nat. Rev. Drug Discov., 7, 759, 10.1038/nrd2638 Eltzschig, 2006, ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function, Circ. Res., 99, 1100, 10.1161/01.RES.0000250174.31269.70 Chen, 2006, ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors, Science, 314, 1792, 10.1126/science.1132559 Decking, 1997, Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release, Circ. Res., 81, 154, 10.1161/01.RES.81.2.154 Linden, 2001, Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection, Annu. Rev. Pharmacol. Toxicol., 41, 775, 10.1146/annurev.pharmtox.41.1.775 Khoury, 2007, Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation, J. Clin. Investig., 117, 703, 10.1172/JCI30049 Hong, 2010, Cyclic AMP inhibits IL-1beta plus IFNgamma-induced NF-kappaB translocation in hepatocytes by a PKA independent mechanism, J. Surg. Res., 159, 565, 10.1016/j.jss.2008.12.018 Majumdar, 2003, Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types, Oncogene, 22, 1206, 10.1038/sj.onc.1206184 Liu, 2009, Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation, J. Biol. Chem., 284, 13686, 10.1074/jbc.M809275200 Gordon, 1986, Extracellular ATP: effects, sources and fate, Biochem. J., 233, 309, 10.1042/bj2330309 Weissmuller, 2008, PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases, J. Clin. Investig., 118, 3682, 10.1172/JCI35874 Colgan, 2006, Physiological roles for ecto-5′-nucleotidase (CD73), Purinergic Signal., 2, 351, 10.1007/s11302-005-5302-5 Madara, 1993, 5′-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers, J. Clin. Investig., 91, 2320, 10.1172/JCI116462 Keely, 2012, Activated fluid transport regulates bacterial-epithelial interactions and significantly shifts the murine colonic microbiome, Gut Microbes, 3, 250, 10.4161/gmic.20529 Curtis, 2015, Stabilization of HIF through inhibition of Cullin-2 neddylation is protective in mucosal inflammatory responses, FASEB J., 29, 208, 10.1096/fj.14-259663 Ehrentraut, 2013, Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response, J. Immunol., 190, 392, 10.4049/jimmunol.1202041 Neish, 2000, Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination, Science, 289, 1560, 10.1126/science.289.5484.1560 Kumar, 2007, Commensal bacteria modulate cullin-dependent signaling via generation of reactive oxygen species, EMBO J., 26, 4457, 10.1038/sj.emboj.7601867 Cope, 2003, COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases, Cell, 114, 663, 10.1016/S0092-8674(03)00722-0 Cardozo, 2004, The SCF ubiquitin ligase: insights into a molecular machine, Nat. Rev., 5, 739, 10.1038/nrm1471 Parry, 2004, Regulation of cullin-based ubiquitin ligases by the Nedd8/RUB ubiquitin-like proteins, Semin. Cell Dev. Biol., 15, 221, 10.1016/j.semcdb.2003.12.003 Kamura, 2004, VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases, Genes Dev., 18, 3055, 10.1101/gad.1252404 Soucy, 2009, An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer, Nature, 458, 732, 10.1038/nature07884 Cowley, 1995, Modulatin of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas, Int. J. Cancer, 60, 325, 10.1002/ijc.2910600308 Mendoza, 2003, NEDP1, a highly conserved cysteine protease that deNEDDylates Cullins, J. Biol. Chem., 278, 25637, 10.1074/jbc.M212948200 Wu, 2003, DEN1 is a dual function protease capable of processing the C terminus of Nedd8 and deconjugating hyper-neddylated CUL1, J. Biol. Chem., 278, 28882, 10.1074/jbc.M302888200 Dye, 2001, Cyclic AMP and acidic fibroblast growth factor have opposing efffects on tight and adherens junctions in microvascular endothelial cells in vitro, Microvasc. Res., 62, 94, 10.1006/mvre.2001.2333 Adamson, 1998, Microvascular permeability and number of tight junctions are modulated by cAMP, Am. J. Physiol., 274, H1885 Lawrence, 2002, Role of VASP in reestablishment of epithelial tight junction assembly after Ca2+ switch, Am. J. Physiol. Cell Physiol., 282, C1235, 10.1152/ajpcell.00288.2001